Quantus

LG Chem

A051910 · KOSPI
₩258,000+5.09%
2026-08-03 close

LG Chem — pricey right now, or cheap? And what signals are flashing today?

Open the exact grade & valuation bands with Pro →
Loading chart…
Close
AI Insight

Why these signals fired — only backtest-proven edge, told honestly

Why this signalSignal guide

Moving-average alignment
No

No active signal.

Explore this stock further
Review signal, financial and filing context in chat
Explore in chat →

Strong-buy signal — the real recordrecord · not a prediction

Not this one stock, but every strong-buy pick we actually published (Korea market). When this stock flashes the signal, it is treated by the same rule.(as of 2026-08-03)

Last 30 sessions
648 picks
Next-day win rate
49.2%
Avg next-day
-0.17%
vs market
+0.72%p

Beat the market on 62.1% of picks (each pick vs its own day’s market average).

Recent publish days (next-day win rate)
07-31 0%07-30 66.7%07-29 0%07-28 45%07-27 20%07-25 36.4%07-21 55.6%07-20 53.8%07-16 53.3%07-15 50%07-14 71.4%07-13 31.2%
This stock flashed this signal 1 time over the last ~2 years (see the signal history below for each date).

Entry is the latest close at publish time; next-day is the following close. “Market” is the equal-weighted average of every stock in the same market that day; delisted names are excluded from both. Fees, taxes and slippage are not included. An observed record over a short window, not a pre-registered backtest. Not investment advice.

Valuation Grades

Relative to 110 화학 peers · not investment advice

Pro unlocks the composite grade, 5 factors and sector rank · ₩19,900/mo

Valuation in its own history

PER — · PBR 0.58 — own history (2001-04~) percentiles 2/100 · 96/100

PER2/100
PBR96/100

Higher indicates lower valuation relative to its history (based on earnings and book yields).

Earnings percentiles can fluctuate for cyclical companies (including loss periods), so the book basis is shown alongside. Companies with large share buybacks can have structurally high PBR. Factual information, not investment advice.

Annual dividend

Split-adjusted annual DPS history and available grade axes

Annual dividend per share chart2002: 1,067원20022003: 2,133원2004: 2,489원2005: 2,133원20052006: 1,778원2007: 1,422원2008: 2,844원2009: 3,556원2010: 3,500원20102011: 4,000원2012: 4,000원2013: 4,000원2014: 4,000원2015: 4,000원20152016: 4,500원2017: 5,000원2018: 6,000원2019: 6,000원2020: 2,000원20202021: 10,000원2022: 12,000원2023: 10,000원2024: 3,500원2025: 1,000원1,000원2025
Annual dividend (per share · split-adjusted) · as of 2025
Consistency
A
Growth
F
Yield
F
Safety
D
Reference indicatorView observed cut rates

Paid 24 consecutive years · Raised 0 consecutive years · Yield 0.39% (based on 2025 payment of 1,000원) · 3-year growth -56.3%

Per-share amount adjusted for splits and capital reductions · Factual information, not investment advice.

Financial safety

Reference indicatorAs of 2024
Grey zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 1.71
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
1.71
Beneish M-Score
-2.82

No statistical flag

Sloan accrual
-8.21%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Why has this company moved this way?

Auditable observations with the original numeric evidence.

매출 하락 → 마진 압박 → 현금 악화

Critical

매출이 -11.5% 감소하며 영업이익률이 4.4%에서 0.5%로 하락했다. 영업현금흐름도 동반 감소하여 수익-현금 순환이 약화되고 있다.

Evidence

매출 YoY -11.5% (2023→2024)영업이익률 4.4%→0.5%영업CF 7,512,585→7,012,339

차입 증가 → 이자부담 → 수익성 악화

Critical

부채가 +33.8% 늘며 이자보상배율이 3.3x에서 0.2x로 하락했다. ROE도 7.6%에서 0.7%로 낮아져 차입 부담이 수익성을 누르고 있다.

Evidence

부채 YoY +33.8%이자보상배율 3.3x→0.2xROE 7.6%→0.7%

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

2/9Weak

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score2/9

Profitability

  • Positive ROANot passed
  • Positive OCFPass
  • Improving ΔROANot passed
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtNot passed
  • Higher current ratioNot passed
  • No new sharesNot passed

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Margin trendWarning

영업외손익 급변 (영업이익 대비 78% 규모 변동) — 일회성 손익 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Industry structure

KRAs of 2026-08-03

화학

This stock is in 화학: revenue rank 1 of 109, share 31.9%.

1 / 10931.9%revenue share

Who dominates this industry?

  1. 1LG화학31.9%
  2. 2롯데케미칼13.3%
  3. 3금호석유화학4.7%
  4. 4DL3.7%
  5. 5코오롱인더3.2%

Concentration

DistributedCR3 49.9%
HHI 1,298109 revenue members

HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.

Polarization

MixedConsistent

Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.

Margin lens

IQR%p
8.66
Direction
확대
Level
보통
Years
6

Value lens

P90/P10
9.3
Median P/B
0.71
Level
넓음
n
98

Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
0.5%
Interest coverage
0.2x
Return on equity (ROE)
-2.1%

Operating margin −5pp

Operating loss
Interest coverageBase 0.2x adverse case -2x
Return on equity (ROE)Base -2.1% adverse case -10%

Revenue −15%

Interest coverage risk
Interest coverageBase 0.2x adverse case 0.2x
Return on equity (ROE)Base -2.1% adverse case -2.7%

Interest rate +2pp

Interest coverage risk
Interest coverageBase 0.2x adverse case 0.1x
Return on equity (ROE)Base -2.1% adverse case -6.3%

Interest coverage limit

Already below the limit by 1.8pp

Interest coverage limit at an operating margin of 2.3%

Interest expense coverage threshold

Key suppliers · Annual report

Annual reportDART · 2026-03-13

Suppliers disclosed by the company in its 2026-03-13 annual report.

Purchase amount

KRW 100m
  1. Naphtha
    KRW 2,331.4T
  2. USD
    KRW 2,331.4T
  3. Caltex
    KRW 1,108.7T
  4. Mitsui
    KRW 1,108.7T
  5. NICHIA
    KRW 981.5T
  6. Huayou
    KRW 146.7T
  7. Agro
    KRW 8.4T
  8. Recordati
    KRW 8.4T
  9. Sinochem
    KRW 8.4T
  10. Techwell
    KRW 8.4T

Suppliers without disclosed amount

EDCPVCMitsubishiApplicationFluazinamTebupirimfosEtofenprox

Financials at a glance

LG Chem's latest results and balance sheet. The bars track the last three periods.

Who held it · filings

Filed record

A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.

US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.

5%+ major-holding disclosures

  • LG34.98%2025-03-07 · 증감 +0.91%p
  • 국민연금공단8.64%2025-04-01 · 증감 +1.04%p
  • BlackRockFundAdvisors5.01%2026-03-05 · 증감 +0.08%p

Other stocks held by the same investors

A filing-based shared-holder record, not investment advice.

📦 ETFs holding this stock

by weight · top-10 constituents basis

Passive money holding this stock ≈ 4,992억 · 1w net inflow ≈ +17억(lower bound — top-10 basis, not a forecast)

Factual holdings info from daily disclosures — not a recommendation.

Look up another stock →

Recent filings

LG Chem's latest filings on Korea's DART. Open a headline for a reference summary and the original.

Source: DART (Korea electronic disclosure)

Signal history (last ~2 years)

Every occurrence on this stock, with the return 20 trading days later. Small sample — a record, not a prediction.

Strong buy (52w high + volume)×1
26-05-04-17.9%
52-week high breakout×3
26-05-08-23.4%26-05-06-17.6%26-05-04-17.9%

“·” = fewer than 20 trading days since the event. Cup-and-handle entries are days our board actually showed the badge (archive grows daily since 2026-05-12); others are recomputed from price data.

Like these rules? Run them automatically.

Quantus turns rules like these into backtests and automated trading — same team, free to start.

Quantus Signal · live data · not investment advice · Privacy Policy